Discovery of novel A3 adenosine receptor ligands based on chromone scaffold

被引:43
作者
Gaspar, Alexandra [1 ]
Reis, Joana [1 ]
Kachler, Sonja [3 ]
Paoletta, Silvia [4 ]
Uriarte, Eugenio [1 ,2 ,3 ,4 ]
Klotz, Karl-Norbert [3 ]
Moro, Stefano [4 ]
Borges, Fernanda [1 ]
机构
[1] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, CIQUP, P-4169007 Oporto, Portugal
[2] Univ Santiago de Compostela, Fac Farm, Dept Quim Organ, Santiago De Compostela 15782, Spain
[3] Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany
[4] Univ Padua, Dipartimento Sci Farmaceut, MMS, I-35131 Padua, Italy
关键词
Drug discovery; Adenosine receptor ligand; Chromone scaffold; RESIDUES; AGONISTS; DOCKING; BINDING;
D O I
10.1016/j.bcp.2012.03.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A project focused on the discovery of new chemical entities (NCEs) as AR ligands that incorporate a benzo-gamma-pyrone [(4H)-1-benzopyran-4-one] substructure has been developed. Accordingly, two series of novel chromone carboxamides placed at positions C2 (compounds 2-13) and C3 (compounds 15-26) of the gamma-pyrone ring were synthesized using chromone carboxylic acids (compounds 1 or 14) as starting materials. From this study and on the basis of the obtained structure-activity relationships it was concluded that the chromone carboxamide scaffold represent a novel class of AR ligands. The most remarkable chromones were compounds 21 and 26 that present a better affinity for A(3)AR (K-i = 3680 nM and K-i = 3750 nM, respectively). Receptor-driven molecular modeling studies provide information on the binding/selectivity data of the chromone. The data so far acquired are instrumental for future optimization of chromone carboxamide as a selective A(3)AR antagonist. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 35 条
  • [1] Targeting cell signaling pathways for drug discovery: An old lock needs a new key
    Aggarwal, Bharat B.
    Sethi, Gautam
    Balaclandayuthapani, Veera
    Krishnan, Sunil
    Shishodia, Shishir
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (03) : 580 - 592
  • [2] Metal-catalysed approaches to amide bond formation
    Allen, C. Liana
    Williams, Jonathan M. J.
    [J]. CHEMICAL SOCIETY REVIEWS, 2011, 40 (07) : 3405 - 3415
  • [3] [Anonymous], MOL OP ENV VERS 2008
  • [4] [Anonymous], 1997, NAUNYN SCHMIEDEBERGS, DOI DOI 10.1007/PL00005131
  • [5] Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
  • [6] Adenosine receptor antagonists: Translating medicinal chemistry and pharmacology into clinical utility
    Baraldi, Pier Giovanni
    Tabrizi, Mojgan Aghazadeh
    Gessi, Stefania
    Borea, Pier Andrea
    [J]. CHEMICAL REVIEWS, 2008, 108 (01) : 238 - 263
  • [7] Baraldi PG, 2010, A3 ADENOSINE RECEPTORS FROM CELL BIOLOGY TO PHARMACOLOGY AND THERAPEUTICS, P121, DOI 10.1007/978-90-481-3144-0_7
  • [8] Borea PA, 2010, A3 ADENOSINE RECEPTORS FROM CELL BIOLOGY TO PHARMACOLOGY AND THERAPEUTICS, P1, DOI 10.1007/978-90-481-3144-0
  • [9] Borges F, GOLD SUITE VERSION 4, Patent No. WO 2008/104925
  • [10] Borges M.F.M., [No title captured], Patent No. [PT103665, 103665]